Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
INFECTIOUS DISEASES - HEPATITIS
LIAISON® HBsAg |
310100 |
Intended use |
For the qualitative determination of Hepatitis B Surface Antigen (HBsAg) |
Material provided |
Reagent integral for 100 determinations |
Method |
2 step immunoluminometric sandwich assay using magnetic microparticles |
Calibrators |
Included |
Incubations |
30 min |
Sample type |
Serum/Plasma |
HBsAg Confirmatory Test |
310110 |
Intended use |
For confirmation of the presence of Hepatitis B Surface Antigen (HBsAg) in repeatedly reactive samples |
Material provided |
Reagent (anti-HBs + specimen diluent) for 20 determination to be used with LIAISON® HBsAg |
Method |
Pretreatment of samples with anti-HBs antibody and specimen diluent followed by 2-step assay |
Incubations |
1h/RT + 20 min |
Sample type |
Serum/Plasma |
Sample size |
700 µL |
LIAISON® anti-HBs |
310120 |
Intended use |
For the quantitative determination of antibodies to Hepatitis B Surface Antigen (anti-HBs) |
Material provided |
Reagent integral for 100 determinations. |
Method |
2 step immunoluminometric sandwich assay using magnetic microparticles |
Calibrators |
Included ( WHO 1st Int'l Reference Preparation, 1977) |
Incubations |
30 min |
Sample type |
Serum/Plasma |
LIAISON® anti-HBs PLUS |
310190 |
Intended use |
For the quantitative determination of antibodies to Hepatitis B Surface Antigen (anti-HBs), with addional Specimen Diluent available for dilution of samples > 1000 mIU/mL |
Material provided |
Reagent integral for 100 determinations. |
Diluent |
Included |
Method |
2 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® HBeAg |
310150 |
Intended use |
For the quantitative determination of Hepatitis B e Antigen (HBeAg) |
Material provided |
Reagent integral for 100 determinations. |
Method |
1 step immunoluminometric sandwich assay using directly coated magnetic microparticles |
Calibrators |
Included (PEI, HBe Reference Antigen 82 Preparation) |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® anti-Hbe |
310160 |
Intended use |
For the qualitative determination of antibodies to Hepatitis B e Antigen (HBeAg) |
Material provided |
Reagent integral for 100 determinations. |
Method |
2 step immunoluminometric competitive assay using magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® anti-HBc |
310130 |
Intended use |
For the qualitative determination of total antibodies to Hepatitis B core Antigen (anti HBc) |
Material provided |
Reagent integral for 100 determinations. |
Method |
2 step immunoluminometric competitive assay using magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® HBc IgM |
310140 |
Intended use |
For the qualitative determination of IgM antibodies to Hepatitis B core Antigen (IgM anti-HBc) |
Material provided |
Reagent integral for 50 determinations. |
Method |
2 step immunoluminometric capture assay using magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |
LIAISON® anti-HAV |
310170 |
Intended use |
For the qualitative determination of total antibodies to Hepatitis A virus (anti-HAV) |
Material provided |
Reagent integral for 100 determinations. |
Method |
2 step immunoluminometric competitive assay using magnetic microparticles |
Calibrators |
Included |
Incubations |
30 min |
Sample type |
Serum/Plasma |
LIAISON® HAV IgM |
310180 |
Intended use |
For the qualitative determination of IgM antibodies to Hepatitis A virus |
Material provided |
Reagent Integral for 100 determinations |
Method |
2 step immunoluminometric capture assay using magnetic microparticles |
Calibrators |
Included |
Incubations |
20 min |
Sample type |
Serum/Plasma |


